Shilpa Medicare Ltd has received US Food and Drug Administration (FDA) final approval for its ANDA, Erlotinib tablets, 25 mg, 100 mg, and 150 mg. Erlotinib tablets, 25 mg, 100 mg, and 150 mg is a generic equivalent of reference listed drug Tarceva used in the treatment of patients with metastatic non-small cell lung cancer (NSCLC) and locally advanced, unresectable or metastatic pancreatic cancer as recommended in the label approved by FDA. According to IQVIA MAT Q2 2019 data, the US market for Erlotinib tablets is approximately US$ 172 million.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!